Turgut Pharmaceuticals, with its R&D investments, ranked 2nd among pharmaceutical companies in the R&D 250 List with 2020 data and ranked 30th among all companies. With the data for 2021, it ranked 5th among pharmaceutical companies and 69th among all companies.
The SR4SB Project, managed by Turgut Pharmaceuticals, Inc., was selected as the European First in the 2022 EURIPIDES² Innovation Awards.
25 November 2022_SR4SB (Sensing Robotics for Smarter Biotechnology), a project within the EUREKA Cluster EURIPIDES², managed by the Industry Association AENEAS, of which Turgut Pharmaceuticals, Inc. is the Project Manager and Robotek, Centi, and BeyonDevices are the project partners, was awarded the 2022 EURIPIDES² Innovation Award at the EFECS2022 event.